New Diagnostic Products Detect Prostate Cancer

Laboratories that are not equipped to use the IVD PCR kit can have samples processed at MDxHealth’s state-of-the-art ISO-certified diagnostic facilities in Nijmegen, the Netherlands or Irvine, California, USA.

“Many of our current customers are eager to start using the IVD PCR kit so they can run the SelectMDx for prostate cancer test in their own labs,” said Dr. Jan Groen, CEO of MDxHealth. “It is well-timed that our UrNCollect device is launching as a complement to the SelectMDx IVD PCR kit because pilot studies demonstrated that patients and physicians found the device easier to use than traditional urine collection tubes.”

A technical validation study that assessed and confirmed the robustness, reproducibility, and interlaboratory performance of SelectMDx was published in the May 11, 2017, issue of the journal Translational Medicine Communications.

Related Links:
MDxHealth